Canadian Pharmacy Blog

The first generic version of Bristol-Myers Squibb’s Generic Pravachol (Pravastatin Sodium Tablets) has been approved. Pravastatin medication is indicated for the treatment of patients with high cholesterol levels or who are at increased risk for atherosclerosis-related cardiac and cardiovascular events (e.g., heart attack and stroke). Bristol-Myers Squibb’s patent for the drug expired on April 20, [...]

Barr Pharmaceuticals, Inc. and its subsidiary Pliva d.d. have announced that Pliva has received final approval from the FDA for its ANDA to manufacture and market Pravastatin tablets in dosages of 10 mg, 20 mg, and 40 mg. The tablets are the generic version of Bristol-Myers Squibb’s Pravachol tablets. Pliva has also received tentative ap­proval [...]